Rapport Therapeutics, Inc. Common Stock (RAPP) Insider Trading
- $1,320,014.64
- $20,624,426.82
- April 17, 2026
- Krishnaswamy Yeleswaram
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 17, 2026 | Major Shareholder | 426,005 | $40.32 | Sell | $17,176,521.60 | |
| April 17, 2026 | Insider | 20,225 | $39.99 | Sell | $808,797.75 | |
| April 14, 2026 | Insider | 10,200 | $35.08 | Sell | $357,816.00 | |
| April 13, 2026 | Insider | 9,165 | $34.97 | Sell | $320,500.05 | |
| April 10, 2026 | Insider | 500 | $34.98 | Sell | $17,490.00 | |
| April 8, 2026 | Insider | 360 | $34.90 | Sell | $12,564.00 | |
| Feb. 18, 2026 | CEO | 5,833 | $29.34 | Sell | $171,140.22 | |
| Feb. 17, 2026 | Insider | 8,500 | $29.02 | Sell | $246,670.00 | |
| Sept. 17, 2025 | CEO | 40,835 | $26.32 | Sell | $1,074,777.20 | |
| Sept. 11, 2025 | Director | 3,500 | $22.60 | Buy | $79,100.00 | |
| Sept. 8, 2025 | COO | 5,000 | $38.33 | Sell | $191,650.00 | |
| Aug. 15, 2025 | Insider | 8,500 | $15.00 | Sell | $127,500.00 | |
| July 15, 2025 | Insider | 8,500 | $14.00 | Sell | $119,000.00 | |
| March 12, 2025 | CFO | 9,900 | $10.10 | Buy | $99,990.00 | |
| March 12, 2025 | Director | 6,000 | $10.21 | Buy | $61,260.00 | |
| July 1, 2024 | Director | 44,032 | $24.52 | Buy | $1,079,664.64 |
Insiders are both buying and selling Rapport Therapeutics, Inc. Common Stock stock.
The insider traders at Rapport Therapeutics, Inc. Common Stock are: Krishnaswamy Yeleswaram, David Bredt, Wendy B Young, Abraham Ceesay, Cheryl Gault, Rock Ventures V L.P. Third, Troy A Ignelzi, and James Healy
The most active insider trader at Rapport Therapeutics, Inc. Common Stock is Krishnaswamy Yeleswaram with 5 trades.
Rock Ventures V L.P. Third has sold the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $34,353,043.20.
James Healy has bought the most Rapport Therapeutics, Inc. Common Stock stock with a total value of $2,159,329.28.
The most recent insider trade for Rapport Therapeutics, Inc. Common Stock was on April 17, 2026.
The single biggest insider buy for Rapport Therapeutics, Inc. Common Stock was from James Healy with a total value of $1,079,664.64 on July 1, 2024.
The single biggest insider sell for Rapport Therapeutics, Inc. Common Stock was from Rock Ventures V L.P. Third with a total value of $17,176,521.60 on April 17, 2026.